MGX

$0.00

(

+0.00%

)
Quote details

stock

Metagenomi, Inc. Common Stock

NASDAQ | MGX

1.88

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 17, 2025)

$68.69M

Market Cap

-

P/E Ratio

-2.33

EPS

$4.92

52 Week High

$1.23

52 Week Low

HEALTHCARE

Sector

MGX Chart

Recent Chart
Price Action

MGX Technicals

Tags:

MGX Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $52M
Total Revenue $52M
Cost Of Revenue $5.4M
Costof Goods And Services Sold $5.4M
Operating Income -$89M
Selling General And Administrative $32M
Research And Development $109M
Operating Expenses $141M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.4M
Income Before Tax -$84M
Income Tax Expense -$5.5M
Interest And Debt Expense -
Net Income From Continuing Operations -$78M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$83M
Net Income -$78M

Revenue & Profitability

Earnings Performance

MGX Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $325M
Total Current Assets $258M
Cash And Cash Equivalents At Carrying Value $27M
Cash And Short Term Investments $27M
Inventory -
Current Net Receivables $1.3M
Total Non Current Assets $67M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $3.4M
Short Term Investments $221M
Other Current Assets $8.4M
Other Non Current Assets -
Total Liabilities $90M
Total Current Liabilities $37M
Current Accounts Payable $533K
Deferred Revenue -
Current Debt -
Short Term Debt $11M
Total Non Current Liabilities $52M
Capital Lease Obligations $46M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $46M
Other Current Liabilities $2.8M
Other Non Current Liabilities $2M
Total Shareholder Equity $235M
Treasury Stock -
Retained Earnings -$223M
Common Stock $4K
Common Stock Shares Outstanding $37M

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$109M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.4M
Capital Expenditures $3.1M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$88M
Cashflow From Financing $84M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$78M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $52M
Total Revenue $52M
Cost Of Revenue $5.4M
Costof Goods And Services Sold $5.4M
Operating Income -$89M
Selling General And Administrative $32M
Research And Development $109M
Operating Expenses $141M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.4M
Income Before Tax -$84M
Income Tax Expense -$5.5M
Interest And Debt Expense -
Net Income From Continuing Operations -$78M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$83M
Net Income -$78M

MGX News

MGX Profile

Metagenomi, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Metagenomi, Inc. is an innovative biotechnology company specializing in gene editing therapies, leveraging a unique metagenomics-derived genome editing toolbox to address unmet medical needs. Headquartered in Emeryville, California, Metagenomi is at the forefront of genetic medicine, focusing on developing transformative therapeutics for patients across various indications. With a commitment to advancing precision medicine, the company aims to revolutionize the treatment landscape through its proprietary technologies and strategic partnerships.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.